Global Innovative Platforms Inc. (GIPL)

Market Cap	24.55M +17,589.5%
Revenue (ttm)	136.50K
Net Income	-647.25K
EPS	-0.01
Shares Out	49.10M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.5000
Previous Close	0.5000
Day's Range	0.5000 - 0.5000
52-Week Range	0.1100 - 2.9000
Beta	8,281.89
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About GIPL

Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was ...

• Industry: Shell Companies
• Sector: Financials
• Founded: 2020
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: GIPL